missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ HTR3A Polyclonal Antibody

Goat Polyclonal Antibody
Brand: Invitrogen™ PA518547
This item is not returnable.
View return policy
Description
This antibody is tested in Peptide ELISA: antibody detection limit dilution 128,000.
The product of this gene belongs to the ligand-gated ion channel receptor superfamily. This gene encodes subunit A of the type 3 receptor for 5-hydroxytryptamine, a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. This receptor causes fast, depolarizing responses in neurons after activation. It appears that the heteromeric combination of A and B subunits is necessary to provide the full functional features of this receptor, since either subunit alone results in receptors with very low conductance and response amplitude. Alternatively spliced transcript variants encoding different isoforms have been identified.
Specifications
| HTR3A | |
| Polyclonal | |
| Unconjugated | |
| Htr3a | |
| 5HT3; 5-HT3; 5-HT-3; 5-HT3 receptor; 5HT3 serotonin receptor; 5-HT3A; 5-HT3-A; 5HT3R; 5-HT3R; 5-hydroxytryptamine (serotonin) receptor 3A; 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic; 5-hydroxytryptamine receptor 3; 5-hydroxytryptamine receptor 3A; Htr3; Htr3a; serotonin receptor; Serotonin receptor 3A; serotonin-gated ion channel receptor; truncated receptor | |
| Goat | |
| Ammonium Sulfate Precipitation | |
| RUO | |
| 3359, 79246 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Flow Cytometry, Immunohistochemistry (Paraffin), Immunocytochemistry | |
| 0.5 mg/mL | |
| TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
| P35563, P46098 | |
| Htr3a | |
| Synthetic peptide sequence (GPQDFEKSPRDR) corresponding to the internal amino acids of HTR3A (aa 390-401). | |
| 100 μg | |
| Primary | |
| Human, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction